What are the clinical manifestations of subacute bacterial peritonitis in a patient undergoing peritoneal dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Manifestations of Subacute Bacterial Peritonitis in Peritoneal Dialysis Patients

Subacute bacterial peritonitis in peritoneal dialysis patients presents most commonly with abdominal pain (80-86%), cloudy peritoneal effluent (71%), and abdominal distension, though notably it may be completely asymptomatic in some cases, particularly in outpatients. 1, 2

Primary Clinical Features

The clinical presentation differs from acute peritonitis and includes:

Cardinal Symptoms (in order of frequency):

  • Abdominal pain - present in 80-86% of cases 1, 2, 3
  • Cloudy peritoneal dialysate - observed in 71% 2
  • Abdominal distension - common presenting feature 4
  • Nausea and vomiting - occurs in 34-42% 1, 3
  • Diarrhea - may be present 1
  • Malaise/general unwellness - frequently reported 4

Critical Clinical Caveat:

Fever is often absent in subacute presentations - this is a key distinguishing feature from acute peritonitis. The absence of fever should not delay diagnosis or treatment 4, 2. Some patients may even present with hypothermia rather than fever 1.

Laboratory and Diagnostic Findings

Peritoneal Effluent Analysis (Diagnostic):

  • White blood cell count >100 cells/mm³ (98% sensitivity) 1, 5
  • Neutrophil count >250 cells/mm³ provides greatest sensitivity for diagnosis 1
  • In subacute/chronic presentations, mononuclear cell predominance may be observed rather than neutrophil predominance 4

Systemic Laboratory Abnormalities:

  • Elevated C-reactive protein - found in 58-69% 4, 2
  • Mildly elevated procalcitonin 4
  • Normal or low peripheral white blood cell count - paradoxically, systemic leukocytosis may be absent 4
  • Elevated erythrocyte sedimentation rate - present in 69% 2
  • Hypoalbuminemia - associated with peritonitis episodes 3, 6
  • Anemia, azotemia, hyperglycemia, hyponatremia - commonly present 3

Secondary Manifestations

Patients may develop:

  • Worsening liver function (in cirrhotic patients) 1
  • Hepatic encephalopathy 1
  • Renal failure progression 1
  • Shock (in severe cases) 1
  • Gastrointestinal bleeding 1

Asymptomatic Presentations

A critical pitfall: spontaneous bacterial peritonitis may be completely asymptomatic, particularly in outpatient settings 1. This underscores the importance of routine surveillance paracentesis in high-risk patients rather than relying solely on symptom-based diagnosis.

Microbiological Patterns Influencing Presentation

The causative organism influences clinical presentation:

  • Gram-positive organisms (61% of cases): typically coagulase-negative staphylococci (22-31%) and S. aureus (9-14%) - may present more indolently 2, 5, 6
  • Gram-negative organisms (31%): E. coli, Klebsiella, Enterobacter - may present more acutely 2, 6
  • Fungal peritonitis (Candida species): associated with higher leukocyte counts and cellularity in peritoneal fluid 3
  • Culture-negative peritonitis: occurs in 40-60% of cases despite clinical manifestations 1, 2

Risk Factors Associated with Clinical Presentation

Patients more likely to develop peritonitis manifestations include those with:

  • Diabetes mellitus as primary cause of renal failure (67% of cases) 3
  • Hypoalbuminemia at baseline 6
  • Obesity or overweight status 2
  • Prolonged duration of PD catheterization 2
  • Recent antibiotic exposure or hospitalization 7

Distinguishing from Other Conditions

Important differential: Clostridioides difficile infection can present identically to PD-associated peritonitis with abdominal pain, diarrhea, and cloudy dialysate 7. Consider CDI testing in patients with:

  • Watery diarrhea as prominent feature
  • Recent antibiotic exposure
  • Lack of response to standard intraperitoneal antibiotics
  • Recent hospitalization

The key to diagnosis remains diagnostic paracentesis with cell count and differential - this should be performed in all PD patients with any suggestive symptoms or unexplained clinical deterioration, even in the absence of classic peritonitis signs 1.

Related Questions

What is the differential diagnosis for new abdominal pain in a patient receiving peritoneal dialysis?
When should albumin be administered for large-volume paracentesis and for treatment of spontaneous bacterial peritonitis?
What is the recommended antibiotic rotation strategy for spontaneous bacterial peritonitis prophylaxis in adults with decompensated cirrhosis and persistent ascites?
What are the clinical signs of peritonitis?
What is the next step in management for a 29-year-old female with abdominal pain, mild ascites, bilateral pleural effusion, pericardial effusion, severe pulmonary arterial hypertension, splenomegaly, dilated portal vein, high serum‑ascites albumin gradient low‑protein ascites, transudative pleural fluid with high serum‑pleural albumin gradient, who has responded to diuretics and antibiotics and has no evidence of spontaneous bacterial peritonitis?
Can I experience palpitations with a serum potassium of 3.7 mEq/L?
How should sulpiride be used in the treatment of anxiety disorders?
What is the recommended empirical antibiotic regimen and overall management for subacute bacterial peritonitis, particularly in patients on peritoneal dialysis?
What is the optimal imaging modality for evaluating a suspected inguinal hernia?
In a patient with a small drained pustule on the left nasal bridge who is already on doxycycline and has no current eyelid swelling or drainable collection, should any additional antibiotic (systemic or topical) be added to prevent spread to the eyelid?
What is the recommended treatment for Cushing disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.